Literature DB >> 18081237

Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt.

Chiara Giannarelli1, Antonio De Giorgi, Ferdinando De Negri, Franco Carmassi.   

Abstract

We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18081237      PMCID: PMC4205467          DOI: 10.3748/wjg.v13.i47.6439

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

Review 1.  Clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Nazzareno Galiè; Lewis J Rubin; David Langleben; Werner Seeger; Guido Domenighetti; Simon Gibbs; Didier Lebrec; Rudolf Speich; Maurice Beghetti; Stuart Rich; Alfred Fishman
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

Review 2.  Portopulmonary hypertension.

Authors:  Michael Passarella; Michael B Fallon; Steven M Kawut
Journal:  Clin Liver Dis       Date:  2006-08       Impact factor: 6.126

Review 3.  Clinical management of portopulmonary hypertension.

Authors:  Nga Lei Tam; Xiao-Shun He
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-10

4.  Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics.

Authors:  A Hadengue; M K Benhayoun; D Lebrec; J P Benhamou
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

5.  Systemic and regional changes in plasma endothelin following transient increase in portal pressure.

Authors:  Dharmesh Kapoor; Doris N Redhead; Peter C Hayes; David J Webb; Rajiv Jalan
Journal:  Liver Transpl       Date:  2003-01       Impact factor: 5.799

Review 6.  Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations.

Authors:  B D Robalino; D S Moodie
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

  6 in total
  1 in total

1.  Murine study of portal hypertension associated endothelin-1 hypo-response.

Authors:  Nicholas Theodorakis; Mary Maluccio; Nicholas Skill
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.